Junctional Adhesion Molecule: An Expression in Human Endometrial Carcinoma
Junctional Adhesion Molecule: An Expression in Human Endometrial Carcinoma
复制标题
DOI:
10.1111/igc.0b013e31819bc6e9
复制
发表时间:
2009-02-01
影响因子:
4.8
通讯作者:
Honjo, Hideo
中科院分区:
文献类型:
--
作者:
Koshiba, Hisato;Hosokawa, Kenichi;Honjo, Hideo
Junctional adhesion molecule A (JAM-A) is involved in cell-cell contact and tight junction formation. Loss of cell adhesion molecules may be associated with high histologic grade and invasiveness of endometrial carcinoma. We attempted to determine JAM-A expression in human endometrial carcinoma and its correlations with pathologic features, stage, and survival. Junctional adhesion Molecule A expression in human endometrial carcinoma was evaluated by immunohistochemistry. In addition, we cultured human well and poorly differentiated endometrial adenocarcinoma cell lines, Ishikawa cells, and KLE in 3-dimensional basement membrane preparation, and JAM-A expression in these cells was assessed by real-time reverse transcription-polymerase chain reaction and immunohistochemistry. Junctional adhesion molecule A immunostaining intensity was negatively correlated with histologic grade (tau = -0.420, P < 0.0001), myometrial invasion (tau = -0.306, P < 0.01) and stage (tau = -0.383, P < 0.0001). Low JAM-A immunostaining intensity was associated With Positive Vascular space involvement (P < 0.01). Moreover, low immunostaining intensity was significantly (P < 0.0001) related to low overall survival rate and progression-free survival rate. Additionally, in our 3-dimensional epithelial cell culture, JAM-A expression in poorly differentiated adenocarcinoma was significantly lower than that in well-differentiated adenocarcinoma (P < 0.001). Junctional adhesion molecule A expression seems to be reduced in high-grade or advanced endometrial carcinoma and may be a prognostic factor.